Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

CAFFEINE-BENZOATE SODIUM solution for subcutaneous injection 200mg/ml (1ml), ampoules 10pcs

🔥 5 items sold in last 3 hours
5 people are viewing this product
Active Ingredient:

Manufacturer:

$9.5

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

CAFFEINE-BENZOATE tablets 100mg, 10pcs

$17.5
Add to cart

Analogs of CAFFEINE-BENZOATE SODIUM

ASCOFEN™ ULTRA tablets 250mg+65mg+250mg, 10pcs

$15.0
Add to cart

ASCOFEN™ ULTRA tablets 250mg+65mg+250mg, 20pcs

$15.0
Add to cart

ASCOFEN-P™ tablets 200mg+40mg+200mg, 10pcs

$9.5
Add to cart

ASCOFEN-P™ tablets 200mg+40mg+200mg, 20pcs

$15.0
Add to cart

Table of Contents

CAFFEINE-BENZOATE SODIUM 200mg Solution Buy Online

CAFFEINE-BENZOATE SODIUM Solution for Injection: A Comprehensive Overview

Caffeine-benzoate sodium solution for injection is a powerful medication with a unique mechanism of action, offering a multifaceted approach to various medical conditions. Its stimulating properties and ability to alleviate certain types of pain make it a valuable tool in specific therapeutic settings. Understanding its properties and potential effects is crucial for healthcare professionals and patients alike.

This injectable solution combines caffeine and sodium benzoate, synergistically enhancing their therapeutic benefits. This combination offers a rapid and efficient delivery system, maximizing the medication’s impact where needed.

While offering significant therapeutic advantages, it’s essential to carefully consider potential side effects and contraindications before using caffeine-benzoate sodium. This comprehensive overview will provide a detailed examination of this medication’s properties, applications, and potential risks.

Understanding Caffeine-Benzoate Sodium

Caffeine-benzoate sodium solution is a parenteral formulation combining two active components: caffeine and sodium benzoate. Each 1ml ampoule contains 200mg of the combined substance, providing 80mg of caffeine and 120mg of sodium benzoate. This specific ratio is crucial for the drug’s effectiveness and is designed to enhance the therapeutic effects of caffeine while mitigating potential adverse reactions.

Caffeine, a well-known central nervous system stimulant, acts by blocking adenosine receptors. This mechanism leads to increased alertness, improved cognitive function, and a reduction in fatigue. Sodium benzoate, a preservative commonly used in pharmaceuticals, plays a supporting role in this formulation, enhancing the stability and bioavailability of the caffeine component. The combination of these two substances provides a unique pharmacological profile that differs significantly from caffeine alone.

The subcutaneous route of administration ensures relatively rapid absorption into the bloodstream, allowing for a quicker onset of action compared to oral administration. This rapid absorption is a significant advantage in situations requiring immediate stimulation of the central nervous system. The precise mechanism of action and the synergistic interplay between caffeine and sodium benzoate in this formulation remain areas of ongoing research, further highlighting the complexity and potential of this medication.

It’s vital to remember that this medication is a powerful stimulant with potential side effects, and it should only be administered under strict medical supervision. The dosage must be carefully tailored to the individual patient’s needs and medical history to minimize the risk of adverse events. Misuse or self-medication is strongly discouraged due to the potential for serious complications.

Mechanism of Action

The primary mechanism of action for caffeine-benzoate sodium involves the central nervous system. Caffeine, a methylxanthine derivative, acts as an adenosine receptor antagonist. By competitively binding to adenosine receptors, caffeine prevents adenosine from exerting its inhibitory effects on neuronal activity, leading to increased neuronal excitability and subsequent stimulation of various brain regions.

This increased neuronal activity translates into several observable effects, including heightened alertness, improved cognitive function, and a reduction in feelings of fatigue or drowsiness. The exact mechanisms by which caffeine enhances cognitive performance are complex and involve interactions with neurotransmitters such as dopamine and norepinephrine. Further research is needed to fully elucidate the intricate pathways involved in these effects.

The role of sodium benzoate in this formulation is less direct but equally important. While not directly involved in the stimulation of the central nervous system, sodium benzoate serves as a preservative, enhancing the stability of the caffeine and extending the shelf life of the injectable solution. This ensures consistent delivery of the active caffeine component, maintaining the efficacy of the medication over time.

The combined effects of caffeine’s adenosine receptor antagonism and sodium benzoate’s preservative action result in a medication that provides a rapid and relatively sustained central nervous system stimulation. This makes caffeine-benzoate sodium a valuable therapeutic option in specific clinical scenarios where such stimulation is medically necessary. However, it is crucial to remember that the powerful effects of this medication necessitate cautious administration and strict adherence to prescribed dosage.

Therapeutic Uses

Caffeine-benzoate sodium injection finds its primary therapeutic applications in situations requiring a rapid and effective central nervous system stimulant. Its ability to counteract fatigue, improve alertness, and enhance cognitive function makes it a valuable tool in specific medical contexts. The rapid onset of action following subcutaneous injection is crucial in certain emergency situations.

One key application lies in the management of respiratory depression, particularly in cases of drug overdose or other conditions causing decreased respiratory drive. By stimulating the respiratory centers in the brainstem, caffeine-benzoate sodium can help restore adequate breathing. However, it’s important to note that this is typically used as an adjunctive treatment and not as a primary treatment modality.

Another important use is in the treatment of severe migraine headaches, where its ability to constrict blood vessels and reduce inflammation may provide relief. While not a first-line treatment for migraine, it can be considered in certain cases, particularly when other therapies have proven ineffective. The efficacy and safety of caffeine-benzoate sodium for migraine management should be carefully considered on a case-by-case basis by a qualified medical professional.

In addition to these applications, caffeine-benzoate sodium has shown promise in treating other conditions such as neonatal apnea and certain types of circulatory collapse. However, the use of caffeine-benzoate sodium in these indications is often limited to specific clinical settings and requires close monitoring by experienced healthcare providers. The precise indications and contraindications should always be determined in consultation with a physician.

Administration and Dosage

Caffeine-benzoate sodium solution is administered via the subcutaneous route. This method of injection delivers the medication directly beneath the skin, allowing for relatively rapid absorption into the bloodstream. The subcutaneous route is preferred over intravenous administration in many cases due to its reduced risk of complications and ease of administration.

Dosage is determined on a case-by-case basis by a healthcare professional, taking into account factors such as the patient’s age, weight, underlying medical conditions, and the specific indication for treatment. The concentration of the solution is 200mg/ml, meaning each 1ml ampoule contains 200mg of the combined caffeine-benzoate sodium compound. Standard dosages are typically expressed in milligrams of the combined active substance.

It’s crucial to emphasize that self-administration of caffeine-benzoate sodium is strongly discouraged. Incorrect dosage or improper injection technique can lead to serious adverse effects. Only trained medical personnel should administer this medication. Always follow the prescribed dosage and administration instructions provided by a qualified healthcare provider. Improper use can result in significant health risks.

Before administering the injection, it is important to inspect the ampoule for any signs of damage or discoloration. The injection site should be cleaned with an appropriate antiseptic solution. Following the injection, the area should be gently massaged to promote absorption. Close monitoring of the patient’s vital signs and response to the medication is essential following administration. Any unusual symptoms should be reported immediately to the attending physician.

Potential Side Effects

While caffeine-benzoate sodium can be a valuable therapeutic agent, it’s crucial to be aware of the potential side effects associated with its use. These side effects, while generally manageable, can range in severity and necessitate careful monitoring of patients receiving this medication. The likelihood and severity of these side effects are often influenced by factors such as dosage, the patient’s individual sensitivity, and the presence of pre-existing medical conditions.

Common side effects often include nervousness, anxiety, insomnia, and restlessness. These are usually mild and transient, often resolving with dose adjustment or discontinuation of the medication. More serious, though less common, side effects may include cardiac arrhythmias, seizures, and gastrointestinal disturbances. The risk of these more serious side effects is typically higher with excessive or inappropriate use.

Other possible adverse reactions can include tremors, headaches, palpitations, and nausea. These side effects may be indicative of an adverse reaction or an overdose. Patients should be carefully monitored for any signs or symptoms of these adverse events. Immediate medical attention should be sought if any serious or concerning symptoms develop after administration. Regular monitoring by healthcare professionals is crucial to minimize risks.

It’s important to note that individual responses to caffeine-benzoate sodium can vary significantly. Some individuals may experience more pronounced side effects than others, even at the same dosage. Therefore, close medical supervision is vital, especially during initial treatment phases. Open communication between the patient and their healthcare provider is key to managing potential side effects effectively and ensuring safe and appropriate use of this medication.

Pros

Caffeine-benzoate sodium solution for injection offers several key advantages, particularly in situations requiring rapid and effective central nervous system stimulation. Its rapid onset of action, following subcutaneous administration, is a significant benefit in emergency settings or when immediate effects are crucial. This rapid action allows for timely intervention in conditions such as respiratory depression or severe migraine.

The combined formulation of caffeine and sodium benzoate offers a synergistic effect, potentially enhancing the therapeutic benefits of caffeine while improving the drug’s stability and bioavailability. This combination may result in a more potent and reliable therapeutic response compared to using caffeine alone. The precise nature of this synergy remains an area of ongoing research and study.

The subcutaneous route of administration provides a relatively easy and safe method of delivery, reducing the risks associated with intravenous injection. This simpler administration method reduces the need for specialized medical equipment and personnel, making it potentially suitable for a wider range of clinical settings. The ease of administration contributes to improved efficiency and reduced healthcare costs.

Finally, in specific therapeutic situations, caffeine-benzoate sodium can be a highly effective treatment option. For instance, it can be a valuable tool in managing conditions like respiratory depression, where rapid stimulation of the respiratory centers is critical. However, it’s vital to emphasize that the use of this medication should always be under strict medical supervision, due to its potent effects and potential side effects.

Cons

Despite its potential therapeutic benefits, caffeine-benzoate sodium injection carries several potential drawbacks that must be carefully considered. The most significant concern is the risk of adverse effects, ranging from mild anxiety and insomnia to more serious cardiac arrhythmias or seizures. The severity of these side effects is often dose-dependent, emphasizing the importance of careful dosage adjustments and close monitoring.

Another significant drawback is the medication’s potential for abuse. Due to its stimulant properties, caffeine-benzoate sodium can be misused, leading to dependence and serious health consequences. This potential for misuse necessitates strict control and careful prescribing practices. The risk of misuse is further heightened in individuals with a history of substance abuse disorders.

Furthermore, caffeine-benzoate sodium is not suitable for all patients. Contraindications exist, including certain heart conditions, anxiety disorders, and pregnancy. Careful consideration of the patient’s medical history and current health status is essential before administering this medication. Pre-existing conditions can significantly increase the risk of adverse reactions.

Finally, the relatively narrow therapeutic window of caffeine-benzoate sodium necessitates precise dosage adjustments. Finding the optimal dose that provides therapeutic benefit while minimizing side effects can be challenging and requires careful titration under the guidance of a healthcare professional. Overdosage can lead to severe adverse events, highlighting the need for cautious administration and close monitoring of the patient’s response.

Contraindications and Precautions

Caffeine-benzoate sodium injection is contraindicated in several situations, highlighting the importance of careful patient selection and assessment before administration. Patients with known hypersensitivity to caffeine or sodium benzoate should absolutely avoid this medication due to the potential for severe allergic reactions. This contraindication underscores the need for thorough allergy screening before treatment.

Individuals with a history of seizure disorders or other conditions predisposing them to seizures should generally not receive caffeine-benzoate sodium, as the medication can lower the seizure threshold. This contraindication stems from caffeine’s stimulatory effects on the central nervous system. Careful consideration of the patient’s seizure history and current neurological status is crucial.

Patients with severe heart conditions, such as uncontrolled arrhythmias or severe heart failure, should also avoid this medication due to its potential to exacerbate these conditions. The stimulatory effects of caffeine on the cardiovascular system can lead to undesirable consequences in individuals with pre-existing cardiac issues. A comprehensive cardiac evaluation is essential before administering caffeine-benzoate sodium.

Furthermore, caution is advised in patients with anxiety disorders or other conditions associated with heightened anxiety levels. Caffeine’s stimulatory effects may worsen anxiety symptoms. Patients with a history of anxiety should be carefully monitored for any signs of increased anxiety following administration. Appropriate management strategies, including dose adjustments or alternative treatments, should be considered.

Conclusion

Caffeine-benzoate sodium solution for injection represents a potent medication with a unique mechanism of action, offering distinct advantages in specific therapeutic situations. Its ability to rapidly stimulate the central nervous system makes it valuable in managing conditions such as respiratory depression and, in select cases, severe migraine. However, its potent effects necessitate careful consideration of potential side effects and contraindications.

The decision to utilize caffeine-benzoate sodium should always be made by a qualified healthcare professional, weighing the potential benefits against the risks for each individual patient. Careful patient selection, precise dosage adjustments, and close monitoring are all crucial for minimizing the risk of adverse events. The efficacy and safety of this medication are highly dependent on appropriate use and medical supervision.

While the rapid onset of action and synergistic effects of the combined formulation offer significant advantages, the potential for serious side effects, including cardiac arrhythmias and seizures, cannot be overlooked. Therefore, this medication should only be used in situations where the potential benefits clearly outweigh the risks. Misuse or self-medication is strongly discouraged due to the potential for serious health consequences.

Further research is needed to fully elucidate the complex mechanisms of action and to further refine the optimal use of caffeine-benzoate sodium in various clinical settings. Ongoing studies will help to better define its role in specific medical conditions and improve our understanding of its potential benefits and limitations. Clinicians should stay abreast of the latest research findings to ensure responsible and effective utilization of this potent medication.

  • Caffeine-Benzoate Sodium Solution For Subcutaneous Injection 200Mg/Ml (1Ml), Ampoules 10Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Caffeine-Benzoate Sodium Solution For Subcutaneous Injection 200Mg/Ml (1Ml), Ampoules 10Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Caffeine-Benzoate Sodium Solution For Subcutaneous Injection 200Mg/Ml (1Ml), Ampoules 10Pcs Buy Online 6
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “CAFFEINE-BENZOATE SODIUM solution for subcutaneous injection 200mg/ml (1ml), ampoules 10pcs”

Your email address will not be published. Required fields are marked

Similar products

NICERGOLINE lyophilisate for injection solution 4mg, 5pcs

$81.0
Add to cart

NADROPARIN calcium injection solution 9500IU/ml (0.4ml, 3800IU), syringes 5pcs

$218.0
Add to cart

MILDRONATE™ capsules 250mg, 40pcs

$87.5
Add to cart

MILDRONATE™ capsules 250mg, 20pcs

$49.0
Add to cart

METUCINVEL™ solution for IV and IM injection 50mg/ml (5ml), 5pcs

$30.5
Add to cart

LIPOBON™ tablets 10mg, 30pcs

$57.0
Add to cart

CURANTYL™ N25 tablets 25mg, 120pcs

$79.5
Add to cart

XANTINOL NICOTINATE solution for IV and IM injection 300mg/2ml (2ml), 10pcs

$19.0
Add to cart

XANTINOL NICOTINATE tablets 150mg, 60pcs

$24.0
Add to cart

CLEXANE™ injection solution 6000 anti-Xa IU/0.6ml (0.6ml), syringes 9pcs

$273.5
Add to cart

CAVERJECT™ lyophilisate for intracavernous injection solution 10mcg, 1pc + solvent 1ml in syringe

$144.0
Add to cart

DUZOFARM™ tablets 200mg, 60pcs

$217.0
Add to cart

DUZOFARM™ tablets 200mg, 90pcs

$281.5
Add to cart

DUZOFARM™ tablets 50mg, 90pcs

$91.5
Add to cart

DUZOFARM™ tablets 200mg, 30pcs

$108.5
Add to cart

DOXI-HEM™ capsules 500mg, 30pcs

$41.0
Add to cart

DOXI-HEM™ capsules 500mg, 90pcs

$90.0
Add to cart

DIBICOR™ tablets 250mg, 60pcs

$34.5
Add to cart

DABIXOM™ capsules 150mg, 60pcs

$189.0
Add to cart

VESSEL™ DUE F capsules 250LE, 60pcs

$294.5
Add to cart

VESSEL™ DUE F solution for IV and IM injection 600LE/2ml (2ml), 10pcs

$314.5
Add to cart

VAZAPROSTAN™ lyophilisate for infusion solution 20mcg+48.2mg, 10pcs

$840.0
Add to cart

VAZAPROSTAN™ lyophilisate for infusion solution 60mcg+49.5mg, 10pcs

$1,266.0
Add to cart

VAZONIT™ prolonged-release tablets 600mg, 20pcs

$57.0
Add to cart
Select your currency